It has been recently reported that truncating PPM1D mutations that induce elevated protein expression, confer cytarabine resistance in AML and force the selective expansion of PPM1D-mutated leukemic cells [29]. The gene discussed is PPM1D; the disease is acute myeloid leukemia.